Taverner J[au] - Search Results

Year	Number of Results
1970	1
1978	2
1981	1
1982	1
1983	1
1995	1
2016	2
2018	1
2019	1
2021	1
2022	0

1

Burden of diagnostic investigations at the end of life for people with chronic obstructive pulmonary disease.

Ross L, Taverner J, John J, Baisch A, Irving L, Philip J, Smallwood N. Ross L, et al. Among authors: taverner j. Intern Med J. 2021 Nov;51(11):1835-1839. doi: 10.1111/imj.14943. Epub 2021 Oct 23. Intern Med J. 2021. PMID: 32548876

2

Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.

Taverner J, Ross L, Bartlett C, Luthe M, Ong J, Irving L, Smallwood N. Taverner J, et al. Intern Med J. 2019 Jan;49(1):66-73. doi: 10.1111/imj.13959. Intern Med J. 2019. PMID: 29740931

3

Prevention of Rh haemolytic disease.

Tovey LA, Murray J, Stevenson BJ, Taverner JM. Tovey LA, et al. Among authors: taverner jm. Br Med J. 1978 Jul 8;2(6130):106-8. doi: 10.1136/bmj.2.6130.106. Br Med J. 1978. PMID: 96908 Free PMC article.

4

Negative EBUS-TBNA Predicts Very Low Prevalence of Mediastinal Disease in Staging of Non-Small Cell Lung Cancer.

Taverner J, Cheang MY, Antippa P, See K, Irving LB, Steinfort DP. Taverner J, et al. J Bronchology Interv Pulmonol. 2016 Apr;23(2):177-80. doi: 10.1097/LBR.0000000000000234. J Bronchology Interv Pulmonol. 2016. PMID: 26905440

5

Safety and Efficacy of Radial EBUS for the Investigation of Peripheral Pulmonary Lesions in Patients With Advanced COPD.

Georgiou HD, Taverner J, Irving LB, Steinfort DP. Georgiou HD, et al. Among authors: taverner j. J Bronchology Interv Pulmonol. 2016 Jul;23(3):192-8. doi: 10.1097/LBR.0000000000000288. J Bronchology Interv Pulmonol. 2016. PMID: 27454473

6

The Yorkshire antenatal anti-D immunoglobulin trial in primigravidae.

Tovey LA, Townley A, Stevenson BJ, Taverner J. Tovey LA, et al. Among authors: taverner j. Lancet. 1983 Jul 30;2(8344):244-6. doi: 10.1016/s0140-6736(83)90232-5. Lancet. 1983. PMID: 6135077 Clinical Trial.

7

A Palliative Approach is Adopted for Many Patients Dying in Hospital with Chronic Obstructive Pulmonary Disease.

Smallwood N, Ross L, Taverner J, John J, Baisch A, Irving L, Philip J. Smallwood N, et al. Among authors: taverner j. COPD. 2018 Oct;15(5):503-511. doi: 10.1080/15412555.2018.1549210. COPD. 2018. PMID: 30822239

8

A case for the antenatal administration of anti-D immunoglobulin to primigravidae.

Tovey LA, Taverner JM. Tovey LA, et al. Among authors: taverner jm. Lancet. 1981 Apr 18;1(8225):878-81. doi: 10.1016/s0140-6736(81)92148-6. Lancet. 1981. PMID: 6112301

9

The effect of environment on ABO antibodies.

Tovey LA, Taverner JM, Longster GH. Tovey LA, et al. Among authors: taverner jm. Vox Sang. 1970 Jul;19(1):64-72. doi: 10.1111/j.1423-0410.1970.tb01496.x. Vox Sang. 1970. PMID: 5488660 No abstract available.

10

Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.

Garner SF, Gorick BD, Lai WY, Brown D, Taverner J, Hughes-Jones NC, Contreras M, Lubenko A. Garner SF, et al. Among authors: taverner j. Vox Sang. 1995;68(3):169-76. doi: 10.1111/j.1423-0410.1995.tb03921.x. Vox Sang. 1995. PMID: 7625074

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results